EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Azithromycin resistance in non-typhoidal Salmonella : a review

Zhe Zhu, Xin Hua, Yefang Ke

Journal of Antimicrobial Chemotherapy · 06.01.2026 · 81 (1)

DOI: 10.1093/jac/dkaf341 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 16.09.2025. Verfasst von Zhe Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood Transfusion, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Azithromycin, Anti-Bacterial Agents, Drug Resistance, Bacterial, Salmonella Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: Medical Scientific Research Foundation of Zhejiang Province, China, Ningbo Natural Science Foundation, Key Discipline of Ningbo No. 2 Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotics are crucial for controlling severe or invasive non-typhoidal Salmonella (NTS) infections. However, the high resistance or toxicity of traditionally first-line antibiotics calls for alternatives. The excellent membrane permeability, long half-life and safe to use in children render azithromycin a promising candidate. However, azithromycin resistance has been observed in NTS isolates recovered from humans, food, animals and the environment, with particularly high rates in Asia. Although azithromycin resistance remains low in Europe, the USA and Australia, an increasing tendency has been noted in the USA in recent years. Macrolide inactivation by phosphotransferases, methylation of 23S rRNA by methyltransferases, ribosomal protein alteration and efflux pumps are involved in azithromycin resistance in NTS isolates, among which phosphotransferase encoded by the mph (A) gene is the predominate mechanism. Current studies face limitations, such as the lack of a standardized azithromycin breakpoint for NTS isolates, insufficient integrated national surveillance and limited robust clinical evidence for treating NTS infections. Therefore, future studies addressing these issues are highly recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzithromycinAnti-Bacterial AgentsDrug Resistance, BacterialSalmonella InfectionsSalmonellaHumansAnimalsUnited StatesEuropeAsiaAustraliaMicrobial Sensitivity Tests

Substanzen

AzithromycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Blood Transfusion, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
  • Department of Clinical Laboratory, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
  • Department of Clinical Laboratory, Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, China.
  • Ningbo Key Laboratory for the Prevention and Treatment of Embryogenic Diseases, Women and Children's Hospital of Ningbo University, Ningbo, China.

Förderung

  • Medical Scientific Research Foundation of Zhejiang Province, China
  • Ningbo Natural Science Foundation
  • Key Discipline of Ningbo No. 2 Hospital
  • Science and Technology Program for Disease Prevention and Control of Zhejiang Province

Zitieren

APA

Zhu, Z., Hua, X., & Ke, Y. (2026). Azithromycin resistance in non-typhoidal Salmonella : a review. Journal of Antimicrobial Chemotherapy, 81(1). https://doi.org/10.1093/jac/dkaf341

Vancouver

Zhu Z, Hua X, Ke Y. Azithromycin resistance in non-typhoidal Salmonella : a review. Journal of Antimicrobial Chemotherapy. 2026;81(1). doi:10.1093/jac/dkaf341

BibTeX
@article{Zhu2026,
  author = {Zhu, Zhe and Hua, Xin and Ke, Yefang},
  title = {Azithromycin resistance in non-typhoidal Salmonella : a review},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {1},
  doi = {10.1093/jac/dkaf341}
}
Kostenlos starten →